NIH 2017
N44 HD |
IGF::CL::IGFMindfulness-Based Substance Abuse Prevention Program for Adolescents with FASD. August 1, 2013 - September 20, 2016Cost Plus Fixed Fee - Completion (SBIR Phase II)
Parker, Alison / Innovation Research and Training, Inc. |
|
NIH 2016
N44 HD |
IGF::OT::IGF -- Biomarkers for Alcohol and ALD
Nielsen, Paul / Echelon Biosciences, Inc. |
|
NIH 2016
N44 HD |
Development of A Database of Non-English Measures & Instruments for Use in Alcohol Researchperiod of Performance 2/29/16 - 2/28/18igf::Ot::Igf
Yang, Dershung / Brightoutcome Inc. |
|
NIH 2016
N44 HD |
Igf::Ot::Igf Potential Commercialization of Proprietary Compound JR-220
Littleton, John / Naprogenix, Inc |
|
NIH 2015
N44 HD |
Development of Nociceptin Receptor Agonists for Alcohol Use Disorders, Period of Performance 09/15/15 - 09/14/17; CPFF
Zaveri, Nurulain / Astraea Therapeutics, LLC |
|
